2006
DOI: 10.1157/13092412
|View full text |Cite
|
Sign up to set email alerts
|

Neumonía adquirida en la comunidad por gérmenes atípicos: tratamiento y evolución

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2006
2006
2015
2015

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 10 publications
(1 citation statement)
references
References 25 publications
0
1
0
Order By: Relevance
“…It is common clinical practice to treat patients with verified or suspected atypical lower respiratory tract infections with macrolides or doxycycline. In the literature, however, the indication for antimicrobial therapy in atypical pneumonia and its effectiveness are discussed rather controversially [8,22,23]. Within a possible prospective PCT-guided intervention trial, children with atypical (predominantly M. pneumoniae and C. pneumoniae, only rare cases of L. pneumophila in childhood) respiratory tract infections and PCT levels <0.1 ng/ml would obviously not be treated with antibiotics.…”
Section: Discussionmentioning
confidence: 99%
“…It is common clinical practice to treat patients with verified or suspected atypical lower respiratory tract infections with macrolides or doxycycline. In the literature, however, the indication for antimicrobial therapy in atypical pneumonia and its effectiveness are discussed rather controversially [8,22,23]. Within a possible prospective PCT-guided intervention trial, children with atypical (predominantly M. pneumoniae and C. pneumoniae, only rare cases of L. pneumophila in childhood) respiratory tract infections and PCT levels <0.1 ng/ml would obviously not be treated with antibiotics.…”
Section: Discussionmentioning
confidence: 99%